Wordt geladen...
The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
BACKGROUND: This study was aimed to assess the efficacy and safety of tocilizumab (TCZ) and to investigate the factors related to the progress and mortality of patients with a secondary cytokine release syndrome caused by SARS-CoV-2. METHODS: A retrospective descriptive observational study of hospit...
Bewaard in:
| Gepubliceerd in: | Pharmacol Rep |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650573/ https://ncbi.nlm.nih.gov/pubmed/33165762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-020-00186-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|